non-nucleoside reverse transcriptase inhibitors (Collaborations Pharmaceuticals)

N/A

Report date: 2025/03/20 09:38:02
NME

Base Information

Drug Namenon-nucleoside reverse transcriptase inhibitors (Collaborations Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReverse transcriptase inhibitors
TargetsReverse transcriptase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCollaborations Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesCollaborations Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A